Optimization of DNA vaccination against cutaneous leishmaniasis. (Q52009810)

19 April 2018

title

Optimization of DNA vaccination against cutaneous leishmaniasis. (English)

1 reference

19 April 2018

author

Yasmine Belkaid

2

1 reference

19 April 2018

author name string

Susana Méndez

1

1 reference

19 April 2018

Robert A Seder

3

1 reference

19 April 2018

David Sacks

4

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 November 2002

1 reference

19 April 2018

published in

Vaccine

1 reference

19 April 2018

volume

20

1 reference

19 April 2018

issue

31-32

1 reference

19 April 2018

page(s)

3702-3708

1 reference

19 April 2018

DNA vaccines: a key for inducing long-term cellular immunity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Expression cloning of a protective Leishmania antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Genetic vaccination against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Naked DNA transport and expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

The immunobiology of muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900376-6

7 January 2021

10.1016/S0264-410X(02)00376-6

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018